Protokinetics For Neurologists
Neurologists commonly see gait disorders in their patients, especially among those with central nervous system abnormalities and brain injuries.
When gait disorders impair posture and the ability to correct orientation, patients frequently fall when bending over or turning. Patients also develop insecure walking due to the fear of falling. Subtle variations in gait can indicate whether this is the onset of a disease or the normal progression of age.
Using observational or bedside diagnostics alone may miss subtle deviations in a patient’s gait, resulting in an incomplete analysis of their condition.
Gait can define the neurological condition
Gait and balance disorders caused by neurological conditions are notoriously difficult to treat. For example, studies have shown that gait in patients with Parkinson’s disease may actually worsen with medication , as a result of medication-induced dyskinesia.
There is also growing evidence that gait variability provides unique information about gait characteristics in neurological disorders.. In one study, patients with Huntington’s Disease showed higher alterations in gait variability than patients with Parkinson’s Disease, Alzheimer’s Disease or Multiple Sclerosis. Quantitative Gait Analysis may significantly improve diagnosis and treatment in patients with these neurological conditions.
Quantitative Gait Analysis like that provided by Protokinetics PKMAS and Zeno Walkway, adds to the neurologist’s diagnostic tools with gait kinematics and gait kinetics data such as:
- temporal and spatial parameters
- coefficient of variation
- relative pressure
- step and stride
- gait phase
- gait cycle
- Center of Pressure (COP)
Measurable & Repeatable Data on Gait Analysis and Balance
Protokinetics gait analysis & assessment systems provide data on the impact of impairments on functional movement.
his allows neurologists a repeatable and precise method of measuring gait when first assessing a patient and in measuring their progress in walking, balance, and coordination.
This data, when compared against a baseline measurement pre-treatment, can help better define treatment protocols and determine when the effect of treatment has plateaued.
PKMAS and Zeno Walkway also offer an opportunity for neurology office staffs to maximize efficiency, as staff can be trained in gait analysis data collection and a physical therapist or Neurologist can interpret the parameters.
This also allows the Neurologist to accurately observe how gait function changes over time during the patient’s treatment.
As healthcare quickly moves to outcomes which require quantitative analysis, shorter hospital stays and increased function, gait analysis will become more useful in identifying levels of patient progress, functional loss or disability.
Protokinetics PKMAS software and Zeno Walkway offer:
- Functional gait outcomes
- Testing treatment efficacy
- Track and report recovery and disease progression longitudinally
- Compare gait conditions to determine optimal performance with assistive devices, such as walker vs. cane vs. FES or SMO vs. AFO (braces)
- Quantify gait analysis to create treatment plans and treatment goals
- Show patients quantitative data to assist with patient compliance
- Send quantitative clinical data to insurance carriers to speed reimbursement